2002
DOI: 10.1159/000056179
|View full text |Cite
|
Sign up to set email alerts
|

Activation of the Metallothionein IIA Promoter and Other Key Stress Response Elements by Ursodeoxycholate in HepG2 Cells: Relevance to the Cytoprotective Function of Ursodeoxycholate

Abstract: Ursodeoxycholate, used to treat a variety of pathologies, has the ability to reverse cytotoxic and hepatotoxic conditions. We examined HepG2, a hepatic cell line, treated with increasing levels of ursodeoxycholate, for responses of a range of promoters/response elements responsive to DNA damage, heavy metal ions, protein denaturants, aromatic hydrocarbons, retinoids, changes in intracellular AMP levels, end endoplasmic reticulum stress. The metallothionein IIA promoter was the most highly activated by ursodeox… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2004
2004
2017
2017

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(11 citation statements)
references
References 36 publications
0
11
0
Order By: Relevance
“…Reduction in ATF4 in cells treated with TUDCA for longer duration (Fig. 6A) may be due to the antioxidant activity associated with TUDCA which can increase thiol containing proteins, scavenge hydroxyl radicals and can also activate metallothionein promoters in hepatocytes and in HepG2 cells 15, 52 . Enhanced levels of eIF2α phosphorylation observed in  cells treated with TUDCA and in UV-irradiation compared to tunicamycin may be a consequence of little or no expression of CHOP that in turn targets the expression of GADD-34, a cofactor of eIF2α phosphatase (Figs 5 and 6).…”
Section: Discussionmentioning
confidence: 99%
“…Reduction in ATF4 in cells treated with TUDCA for longer duration (Fig. 6A) may be due to the antioxidant activity associated with TUDCA which can increase thiol containing proteins, scavenge hydroxyl radicals and can also activate metallothionein promoters in hepatocytes and in HepG2 cells 15, 52 . Enhanced levels of eIF2α phosphorylation observed in  cells treated with TUDCA and in UV-irradiation compared to tunicamycin may be a consequence of little or no expression of CHOP that in turn targets the expression of GADD-34, a cofactor of eIF2α phosphatase (Figs 5 and 6).…”
Section: Discussionmentioning
confidence: 99%
“…UDCA could inhibit tumour development in azoxymethane and dextran-related colitis models by counteracting the tumour-promoting effects of secondary bile acids such as DCA (Earnest et al, 1994;Wali et al, 1995;Loddenkemper et al, 2006). In high-risk patients, retrospective and prospective studies have suggested a beneficial effect of UDCA on colonic carcinogenesis (Kowdley, 2000;Tung et al, 2001;Bernstein et al, 2002;Pardi et al, 2003;Serfaty et al, 2003;Goldman et al, 2010). UDCA supplementation was associated with a nonstatistically significant reduction in total colorectal adenoma recurrence, but with a statistically significant 39% reduction in recurrence of adenomas with high-grade dysplasia (Alberts et al, 2005).…”
Section: Discussionmentioning
confidence: 99%
“…Whether CNT2 plays a role in the response of hepatocytes to apoptosis, either favouring it or acting as a survival signal, is currently under investigation. Nevertheless, it is interesting to note that bile acids have been shown to have a dual role in the programmed cell death of hepatocytes, since hydrophobic (DCA and GCDCA) and hydrophilic (TCA and UDCA) bile acids have been considered to promote apoptosis and to up-regulate selected survival mechanisms respectively [39][40][41]. Moreover, hydrophilic anions such as UDCA and TUDCA are known to be cytoprotective against oxidative stress [42] and to suppress mitochondrial membrane perturbation [43].…”
Section: Discussionmentioning
confidence: 99%